Evidence map›Paper›PMID 26973632›Full record

ArticleFrontiers in microbiology2016

Whole Genome Sequencing for Public Health Surveillance of Shiga Toxin-Producing Escherichia coli Other than Serogroup O157.

Marie A Chattaway, Timothy J Dallman, Amy Gentle, Michael J Wright, Sophie E Long, Philip M Ashton, Neil T Perry, Claire Jenkins

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 65 citations in OpenAlex.

  1. Surveillance of enteropathogenicJournal of medical microbiology · 2026
    Article
  2. Mind the gap! TypingMicrobial genomics · 2026
    Article
  3. An outbreak of Shiga toxin-producingEpidemiology and infection · 2026
    Article
  4. Hybrid strains of enterotoxigenic/Shiga toxin-producingJournal of medical microbiology · 2025
    Article
  5. Epidemiology of Shiga toxin-producingJournal of medical microbiology · 2025
    Article
  6. National outbreak of Shiga toxin-producingEpidemiology and infection · 2024
    Article
  7. Genotypic analysis of Shiga toxin-producingJournal of medical microbiology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Transforming Shiga toxin-producingFrontiers in microbiology · 2023
    Article
  12. Article
  13. Epidemiology and genomic analysis of Shiga toxin-producingJournal of medical microbiology · 2021
    Article
  14. Article
  15. Prevalence of IncFIB Plasmids Found amongPathogens (Basel, Switzerland) · 2021
    Article
  16. Article
  17. The emerging importance of Shiga toxin-producingJournal of medical microbiology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marie A ChattawayGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Timothy J DallmanGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Amy GentleGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Michael J WrightGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Sophie E LongGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Philip M AshtonGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Neil T PerryGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Claire JenkinsGastrointestinal Bacteria Reference Unit, Public Health England London, UK.
Public Health England · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin-producing Escherichia coli (STEC) are considered to be a significant threat to public health due to the severity of gastrointestinal symptoms associated with human infection. In England STEC O157 is the most commonly detected STEC serogroup, however, the implementation of PCR at local hospital laboratories has resulted in an increase in the detection of non-O157 STEC. The aim of this study was to evaluate the use of whole genome sequencing (WGS) for routine public health surveillance of non-O157 STEC by comparing this approach to phenotypic serotyping and PCR for subtyping the stx-encoding genes. Of the 102 isolates where phenotypic and genotypic serotyping could be compared, 98 gave fully concordant results. The most common non-O157 STEC serogroups detected were O146 (22) and O26 (18). All but one of the 38 isolates that could not be phenotypically serotyped (designated O unidentifiable or O rough) were serotyped using the WGS data. Of the 73 isolates where a flagella type was available by traditional phenotypic typing, all results matched the H-type derived from the WGS data. Of the 140 sequenced non-O157 isolates, 52 (37.1%) harboured stx1 only, 42 (30.0%) had stx2 only, 46 (32.9%) carried stx1 and stx2. Of these, stx subtyping PCR results were available for 131 isolates and 121 of these had concordant results with the stx subtype derived from the WGS data. Of the 10 discordant results, non-specific primer binding during PCR amplification, due to the similarity of the stx2 subtype gene sequences was the most likely cause. The results of this study showed WGS provided a reliable and robust one-step process for characterization of STEC. Deriving the full serotype from WGS data in real time has enabled us to report a higher level of strain discrimination while stx subtyping provides data on the pathogenic potential of each isolate, enabling us to predict clinical outcome of each case and to monitor the emergence of hyper-virulent strains.

Indexed as

serotypingShiga Toxin-producing Escherichia colistx subtypingwhole genome sequencing

Identifiers

PMID26973632
PMCPMC4776118
OpenAlexW2300905452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.